相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。PI3K Inhibition Augments the Efficacy of Rapamycin in Suppressing Proliferation of Epstein-Barr Virus (EBV) plus B Cell Lymphomas
S. Furukawa et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response
Heather M. Long et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
A Distinct Subpopulation of Human NK Cells Restricts B Cell Transformation by EBV
Anna Luenemann et al.
JOURNAL OF IMMUNOLOGY (2013)
Mg2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection Through NKG2D
Benjamin Chaigne-Delalande et al.
SCIENCE (2013)
Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
Obinna Chijioke et al.
CELL REPORTS (2013)
Increased CD8+T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
Daniela F. Angelini et al.
PLOS PATHOGENS (2013)
B-cell activation induced microRNA-21 is elevated in circulating B cells preceding the diagnosis of AIDS-related non-Hodgkin lymphomas
Dharma R. Thapa et al.
AIDS (2012)
Immune Regulatory Function of B Cells
Claudia Mauri et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency
Rachel K. Shaw et al.
BLOOD (2012)
Persistence of Epstein-Barr Virus in Self-Reactive Memory B Cells
Sean I. Tracy et al.
JOURNAL OF VIROLOGY (2012)
Src Kinase and Syk Activation Initiate PI3K Signaling by a Chimeric Latent Membrane Protein 1 in Epstein-Barr Virus (EBV) plus B Cell Lymphomas
Olivia Hatton et al.
PLOS ONE (2012)
Epstein-Barr Virus Infection of Naive B Cells In Vitro Frequently Selects Clones with Mutated Immunoglobulin Genotypes: Implications for Virus Biology
Emily Heath et al.
PLOS PATHOGENS (2012)
The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination
Simon Jochum et al.
PLOS PATHOGENS (2012)
Virus-Encoded microRNAs: An Overview and a Look to the Future
Rodney P. Kincaid et al.
PLOS PATHOGENS (2012)
The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
Rebecca L. Skalsky et al.
PLOS PATHOGENS (2012)
Syk Activation of Phosphatidylinositol 3-Kinase/Akt Prevents HtrA2-dependent Loss of X-linked Inhibitor of Apoptosis Protein (XIAP) to Promote Survival of Epstein-Barr Virus plus (EBV plus ) B Cell Lymphomas
Olivia Hatton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
EBV-Specific CD8+ T Cells from Asymptomatic Pediatric Thoracic Transplant Patients Carrying Chronic High EBV Loads Display Contrasting Features: Activated Phenotype and Exhausted Function
Camila Macedo et al.
JOURNAL OF IMMUNOLOGY (2011)
Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection
Claire Shannon-Lowe et al.
PLOS PATHOGENS (2011)
MicroRNAs as Immune Regulators: Implications for Transplantation
A. Harris et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
Pedro P. Medina et al.
NATURE (2010)
The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim
Anthony L. Desbien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisal
Cindy M. Chang et al.
VIRUS RESEARCH (2009)
The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation
Jianmin Zuo et al.
PLOS PATHOGENS (2009)
Tumor-derived Variants of Epstein-Barr Virus Latent Membrane Protein 1 Induce Sustained Erk Activation and c-Fos
Maria Vaysberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products
Maaike E. Ressing et al.
SEMINARS IN CANCER BIOLOGY (2008)
The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function
Jianmin Zuo et al.
JOURNAL OF VIROLOGY (2008)
Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10
Stacie L. Lambert et al.
JOURNAL OF IMMUNOLOGY (2007)
A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates
Andrew D. Hislop et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function
Saparna Pai et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Regulation of the germinal center response by microRNA-155
To-Ha Thai et al.
SCIENCE (2007)
Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression
Maria Vaysberg et al.
TRANSPLANTATION (2007)
Epstein-Barr virus: Evasive maneuvers in the development of PTLD
Andrew L. Snow et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis
Andrew L. Snow et al.
JOURNAL OF IMMUNOLOGY (2006)
LMP1 strain variants: Biological and molecular properties
Bernardo A. Mainou et al.
JOURNAL OF VIROLOGY (2006)
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
S Costinean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8
C Eidenschenk et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan
HJ Lin et al.
JOURNAL OF BIOMEDICAL SCIENCE (2005)
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas
J Kluiver et al.
JOURNAL OF PATHOLOGY (2005)
The immune response to primary EBV infection: a role for natural killer cells
H Williams et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
PS Eis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification of virus-encoded microRNAs
S Pfeffer et al.
SCIENCE (2004)
Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes
KS Voo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer
S Bandyopadhyay et al.
CANCER RESEARCH (2004)
Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1
J Tellam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Multiple Epstein-Barr virus infections in healthy individuals
DM Walling et al.
JOURNAL OF VIROLOGY (2003)
Identification of Epstein-Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients
DA Falco et al.
TRANSPLANTATION (2002)
Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway
AL Snow et al.
JOURNAL OF IMMUNOLOGY (2001)
EBV-infected B cells in infectious mononucleosis:: Viral strategies for spreading in the B cell compartment and establishing latency
J Kurth et al.
IMMUNITY (2000)
X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells
S Parolini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Involvement of two NF-κB binding elements in tumor necrosis factor α, CD40, and Epstein-Barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene
SY Hong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)